Silence Therapeutics (SLN) Other Working Capital Changes (2020 - 2025)
Historic Other Working Capital Changes for Silence Therapeutics (SLN) over the last 6 years, with Q3 2025 value amounting to -$5.3 million.
- Silence Therapeutics' Other Working Capital Changes fell 156013.45% to -$5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.9 million, marking a year-over-year decrease of 52845.95%. This contributed to the annual value of $457998.0 for FY2024, which is 10443.67% up from last year.
- According to the latest figures from Q3 2025, Silence Therapeutics' Other Working Capital Changes is -$5.3 million, which was down 156013.45% from -$3.0 million recorded in Q2 2025.
- Silence Therapeutics' 5-year Other Working Capital Changes high stood at $2.7 million for Q4 2023, and its period low was -$24.2 million during Q4 2024.
- In the last 5 years, Silence Therapeutics' Other Working Capital Changes had a median value of -$920499.3 in 2022 and averaged -$2.4 million.
- In the last 5 years, Silence Therapeutics' Other Working Capital Changes surged by 28716.81% in 2023 and then tumbled by 156013.45% in 2025.
- Over the past 5 years, Silence Therapeutics' Other Working Capital Changes (Quarter) stood at -$3.6 million in 2021, then surged by 119.72% to $701411.1 in 2022, then soared by 287.17% to $2.7 million in 2023, then tumbled by 989.66% to -$24.2 million in 2024, then soared by 77.93% to -$5.3 million in 2025.
- Its last three reported values are -$5.3 million in Q3 2025, -$3.0 million for Q2 2025, and $592000.0 during Q1 2025.